Latest Velcera Inc. (VLCR) Headlines Acquisitions
Post# of 1
Posted On: 03/12/2014 1:06:14 AM
Latest Velcera Inc. (VLCR) Headlines
Acquisitions help lift Perrigo 4Q net income
AP - Thu Aug 15, 11:23AM CDT
ALLEGAN, Mich. (AP) — Drugmaker Perrigo said Thursday that acquisitions boosted its net income in the fiscal fourth quarter as it prepared to buy Irish pharmaceutical company Elan for $8.6 billion.
Perrigo Company acquires USD160m Velcera Inc
M2 - Tue Apr 02, 4:33AM CDT
Healthcare company Perrigo Company (Nasdaq
RGO)(Nasdaq:TASE) reported on Monday the completion of the acquisition of Velcera Inc for a purchase price of about USD160m in cash.
Perrigo Acquisition Of Velcera, Inc. -- Known For Its PetArmor® Franchise Of Flea And Tick Treatments -- Closes Today
PR Newswire - Mon Apr 01, 9:49AM CDT
The sale of privately-held Velcera, Inc. ("Velcera") -- a leading pet health company committed to providing consumers with best-in-class pet health products that contain the same active ingredients as branded veterinary products but at a significantly lower cost -- to Allegan-Mich.-based Perrigo Company (Nasdaq: PRGO; TASE) closed today for approximately $160 million in cash.
Perrigo Company Closes Acquisition Of Companion Animal Health Company, Velcera, Inc.
PR Newswire - Mon Apr 01, 8:17AM CDT
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Velcera, Inc. ("Velcera"), Yardley, Pennsylvania based pet health products company for approximately $160 million in cash.
Law Office of Brodsky & Smith, LLC Announces Investigation of Velcera, Inc.
PR Newswire - Sat Feb 02, 11:00AM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Velcera, Inc. ("Velcera" or the "Company") (OTC: VLCR) relating to the proposed acquisition by Perrigo Company ("Perrigo").
WeissLaw LLP Investigates Velcera, Inc. Acquisition
Business Wire - Fri Feb 01, 11:30AM CST
WeissLaw LLP, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Velcera, Inc. ("Velcera" or the "Company") (OTC: VLCR) arising from its agreement for Velcera to be acquired by Perrigo Company ("Perrigo") in a transaction valued at approximately $160 million. Under the terms of the proposed transaction Velcera shareholders will receive $0.40 in cash for each Velcera share they own.
Perrigo's fiscal 2Q profit rises 6 percent
AP - Fri Feb 01, 9:09AM CST
ALLEGAN, Mich. (AP) — Perrigo Co.'s fiscal second quarter earnings climbed 6 percent in a performance that topped Wall Street expectations, as revenue gains from acquisitions and the over-the-counter drugmaker's consumer health care segment countered rising expenses.
Velcera, Inc. Signs Definitive Agreement to be Acquired by Perrigo Company for $160 Million in Cash
Business Wire - Fri Feb 01, 7:30AM CST
Velcera, a privately-held, developer, manufacturer and marketer of OTC companion animal healthcare products, announced today that it has signed a definitive agreement to be acquired by the Perrigo Company (Nasdaq: PRGO;TASE) for $160 million in cash. The acquisition is expected to close during calendar year 2013 pending the satisfaction of closing conditions, including regulatory approvals. Subject to conditions at the time of closing and based upon current company assumptions, shareholders of Velcera common stock will be entitled to receive approximately $0.40 per share upon consummation of the transaction before allowance for an escrow holdback.
Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
PR Newswire - Fri Feb 01, 6:45AM CST
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive agreement to acquire Yardley, PA based Velcera, Inc. for $160 million in cash. The acquisition is expected to close during calendar year 2013 pending the satisfaction of closing conditions, including regulatory approvals.
Acquisitions help lift Perrigo 4Q net income
AP - Thu Aug 15, 11:23AM CDT
ALLEGAN, Mich. (AP) — Drugmaker Perrigo said Thursday that acquisitions boosted its net income in the fiscal fourth quarter as it prepared to buy Irish pharmaceutical company Elan for $8.6 billion.
Perrigo Company acquires USD160m Velcera Inc
M2 - Tue Apr 02, 4:33AM CDT
Healthcare company Perrigo Company (Nasdaq
RGO)(Nasdaq:TASE) reported on Monday the completion of the acquisition of Velcera Inc for a purchase price of about USD160m in cash. Perrigo Acquisition Of Velcera, Inc. -- Known For Its PetArmor® Franchise Of Flea And Tick Treatments -- Closes Today
PR Newswire - Mon Apr 01, 9:49AM CDT
The sale of privately-held Velcera, Inc. ("Velcera") -- a leading pet health company committed to providing consumers with best-in-class pet health products that contain the same active ingredients as branded veterinary products but at a significantly lower cost -- to Allegan-Mich.-based Perrigo Company (Nasdaq: PRGO; TASE) closed today for approximately $160 million in cash.
Perrigo Company Closes Acquisition Of Companion Animal Health Company, Velcera, Inc.
PR Newswire - Mon Apr 01, 8:17AM CDT
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has closed the acquisition of Velcera, Inc. ("Velcera"), Yardley, Pennsylvania based pet health products company for approximately $160 million in cash.
Law Office of Brodsky & Smith, LLC Announces Investigation of Velcera, Inc.
PR Newswire - Sat Feb 02, 11:00AM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Velcera, Inc. ("Velcera" or the "Company") (OTC: VLCR) relating to the proposed acquisition by Perrigo Company ("Perrigo").
WeissLaw LLP Investigates Velcera, Inc. Acquisition
Business Wire - Fri Feb 01, 11:30AM CST
WeissLaw LLP, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Velcera, Inc. ("Velcera" or the "Company") (OTC: VLCR) arising from its agreement for Velcera to be acquired by Perrigo Company ("Perrigo") in a transaction valued at approximately $160 million. Under the terms of the proposed transaction Velcera shareholders will receive $0.40 in cash for each Velcera share they own.
Perrigo's fiscal 2Q profit rises 6 percent
AP - Fri Feb 01, 9:09AM CST
ALLEGAN, Mich. (AP) — Perrigo Co.'s fiscal second quarter earnings climbed 6 percent in a performance that topped Wall Street expectations, as revenue gains from acquisitions and the over-the-counter drugmaker's consumer health care segment countered rising expenses.
Velcera, Inc. Signs Definitive Agreement to be Acquired by Perrigo Company for $160 Million in Cash
Business Wire - Fri Feb 01, 7:30AM CST
Velcera, a privately-held, developer, manufacturer and marketer of OTC companion animal healthcare products, announced today that it has signed a definitive agreement to be acquired by the Perrigo Company (Nasdaq: PRGO;TASE) for $160 million in cash. The acquisition is expected to close during calendar year 2013 pending the satisfaction of closing conditions, including regulatory approvals. Subject to conditions at the time of closing and based upon current company assumptions, shareholders of Velcera common stock will be entitled to receive approximately $0.40 per share upon consummation of the transaction before allowance for an escrow holdback.
Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
PR Newswire - Fri Feb 01, 6:45AM CST
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive agreement to acquire Yardley, PA based Velcera, Inc. for $160 million in cash. The acquisition is expected to close during calendar year 2013 pending the satisfaction of closing conditions, including regulatory approvals.
(0)
(0)Velcera Inc. (VLCR) Stock Research Links
Scroll down for more posts ▼